A team of LIU researchers advanced a whole-organ virtual liver model in Nature Portfolio’s npj Digital Medicine, outlining multiscale simulations of drug-induced liver injury that can guide safer therapies, accelerate discovery, and reduce reliance on animal testing. The model bridges vascular, lobular, and cellular scales to simulate dynamic blood flow, drug transport, and injury mechanisms that accurately reflect clinically observed spatial heterogeneity.
